What if we could help the body manage inflammation before it becomes dangerous?
At the University of Maryland, Baltimore, researchers Paul Shapiro, PhD, and Jeffrey Hasday, MD, are studying protein kinases — enzymes that regulate immune signaling. Their work could lead to breakthroughs in reducing acute respiratory distress syndrome (ARDS) and related health issues.#BreakthroughsCantWaitUMB #ARDS #MedicalResearch #Inflammation #PharmaceuticalScience #ImmuneBalance #BreakthroughsCantWaitUMB
More from Youtube
- 4:24UMB's 13th Annual Interprofessional Education DayHosted by the University of Maryland Baltimore's Center for Interprofessional Education (CIPE) on April 2, IPE Day brought together more than 170 students from all seven UMB professional schools — including medicine, nursing, pharmacy, law, dentistry, physical therapy, social work, and the Graduate School — for a full afternoon of collaborative learning, simulation activities, and real-life insights into the power of team-based care.Read more: https://www.umaryland.edu/news/archived-news/april-2025/ipe-day-centers-on-listening-to-patients-and-peers.php
- 59:34Virtual Face to Face: The Challenges Facing Academic ResearchThe changes and challenges facing academic research and the University of Maryland, Baltimore's response was the topic of Virtual Face to Face on April 10 hosted by James Hughes, MBA, Chief Enterprise and Economic Development Officer and Senior Vice President. Hughes was joined by University of Maryland School of Medicine Professor and Executive Vice Dean Chris O’Donnell, PhD, and E. Albert Reece, MD, PhD, MBA, Director of the Center for Advanced Research Training and Innovation.
